A study into the way that the tropical parasite Leishmania uses the nutrients they need to grow has provided researchers with drug targets that could be used to combat them.
A study into the way that the tropical parasite Leishmania uses the nutrients they need to grow has provided researchers with drug targets that could be used to combat them.
Leishmania are tropical parasites that proliferate in sandflies and are transferred to mammals when they are bitten by the fly. They infect 12 million people worldwide, causing a range of reactions, from skin conditions to organ infection, and are responsible for 500 000 deaths annually.
A study, published in the Journal of Biological Chemistry,1 has developed an analytical method that has revealed the metabolic pathways essential for the parasite’s survival, down to the particular atoms it uses as a food source. To study the metabolism 13C-labelled carbon sources were introduced into the sugar glucose that the parasites feed on. Gas chromatography–mass spectrometry and nuclear magnetic resonance were then used to follow how the atoms were incorporated by the parasite, revealing the metabolic pathways essential to the parasite’s survival, which would, therefore, be good drug targets to block to kill it.
According to the authors, current anti-parasitic drugs have enormous side effects, as they don’t target specific pathogen metabolic pathways. With a greater understanding of the parasite, specific drugs can be developed with minimal side effects.
1. E.C. Saunders et al., J. Biol. Chem.,286, 27706–27717 (2011).
This story originally appeared in The Column. Click here to view that issue.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.